A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris.

Trial Profile

A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris.

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2012

At a glance

  • Drugs IDP 107 (Primary)
  • Indications Acne vulgaris
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 06 Feb 2012 Actual end date (Dec 2011) added as reported by ClinicalTrials.gov.
    • 03 Nov 2011 Planned End Date changed from 1 Jun 2011 to 1 Nov 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top